Meta-analysis of clinical characteristics of 299 carriers of LMNA gene mutations:: do lamin A/C mutations portend a high risk of sudden death?
Meta-analysis of clinical characteristics of 299 carriers of LMNA gene mutations:: do lamin A/C mutations portend a high risk of sudden death?
复制标题
DOI:
10.1007/s00109-004-0589-1
复制
发表时间:
2005-01-01
影响因子:
4.7
通讯作者:
Pinto, YM
中科院分区:
文献类型:
--
作者:
van Berlo, JH;de Voogt, WG;Pinto, YM
This study evaluated common clinical characteristics of patients with lamin A/C gene mutations that cause either isolated dilated cardiornyopathy or dilated cardiomyopathy in association with skeletal muscular dystrophy. We pooled clinical data of all published carriers of lamin A/C gene mutations as cause of skeletal and/or cardiac muscle disease and reviewed ECG findings. Cardiac dysrhythmias were reported in 92% of patients after the age of 30 years; heart failure was reported in 64% after the age of 50. Sudden death was the most frequently reported mode of death (46%) in both the cardiac and the neuromuscular phenotype. Carriers of lamin A/C gene mutations often received a pacemaker (28%). However, this intervention did not alter the rate of sudden death. Review of the ECG findings typically showed a low amplitude P wave and prolongation of the PR interval with a narrow QRS complex. This meta-analysis suggests that cardiomyopathy due to lamin A/C gene mutations portends a high risk of sudden death, and that this risk does not differ between subjects with predominantly cardiac or neuromuscular disease. This implies then that all carriers of a lamin A/C gene mutation need to be carefully screened with particular emphasis also on tachyarrhythmias. Prospective studies are needed to evaluate risk stratification and proper treatment strategies.